Cold Agglutinin Disease

Landmark Studies in CAD

Sutimlimab in cold agglutinin disease

N Engl J Med. 2021; 384(14): 1323-1334

Sutimlimab in patients with CAD: CADENZA trial

Blood. 2022; 140(9): 980-991

CAD across five countries: a study of 232 patients

Blood. 2020; 136(4): 480-488

Increased risk of thrombotic events in CAD

Res Pract Thromb Haemost. 2020; 4(4): 628-635

Rituximab for primary chronic CAD

Blood. 2004; 103(8): 2925-2928

Effect of ibrutinib on hemolytic anemia and acrocyanosis in CAD/CAS

Blood. 2021; 138(20): 2002-2005